HZNP

Horizon Therapeutics Public Limited Company

NASDAQHealthcareDrug Manufacturers - GeneralIE

USD116.30

+0.00 (+0.00%)

Company Profile

CEO

Timothy P. Walbert

IPO Date

2011-07-28

Sector

Healthcare

Industry

Drug Manufacturers - General

Exchange

NASDAQ

Country

Market Metrics

Open

$116.34

Prev. Close

$116.30

Day Low

$116.30

Day High

$116.34

52W Low

$116.30

52W High

$116.34

Market Cap

$26.60B

Volume

23.92M

News SentimentBullish

Articles

Avg Positive

41.7%

Avg Negative

20.9%

Avg Neutral

37.4%

News Feed

Horizon (HZNP) Begins Phase II Study for Lupus Candidate

Zacks Investment Research·6/30/2021·↑ positive

Horizon Acquires Rights to Arrowhead's RNAi-Based Gout Treatment Candidate

Benzinga·6/21/2021·↑ positive

Horizon Therapeutics plc Announces Multiple Presentations on Neuromyelitis Optica Spectrum Disorder (NMOSD) at the 7th Congress of the European Academy of Neurology (EAN)